Cuban Diabetic Drug Presented In Dominican Republic

News: Cuban scientist Manuel Raices on October 11 promoted a new Cuban pharmaceutical, Heberprot-P, in the Dominican Republic, the 26th country where the drug has been showcased. Heberprot-P is a diabetic foot ulcer treatment developed in Cuba. Raices, a scientist at Cuba's Center of Genetic Engineering and Biotechnology, presented Heberprot-P to doctors and business leaders in the pharmaceutical industry of the Dominican Republic. Raices highlighted that the medicine promotes cicatrisation of lesions and prevents amputations in diabetic patients, thereby enhancing the patient's quality of life. The medicine accelerates speedy granulation and reepithelialisation in patients suffering from ulcers, and reduces recurrences and the need for surgeries, he Raices.

Cuban Diabetic Drug Presented In Dominican Republic

News: Cuban scientist Manuel Raices on October 11 promoted a new Cuban pharmaceutical, Heberprot-P, in the Dominican Republic, the 26th country where the drug has been showcased. Heberprot-P is a diabetic foot ulcer treatment developed in Cuba. Raices, a scientist at Cuba's Center of Genetic Engineering and Biotechnology, presented Heberprot-P to doctors and business leaders in the pharmaceutical industry of the Dominican Republic. Raices highlighted that the medicine promotes cicatrisation of lesions and prevents amputations in diabetic patients, thereby enhancing the patient's quality of life. The medicine accelerates speedy granulation and reepithelialisation in patients suffering from ulcers, and reduces recurrences and the need for surgeries, he Raices.

×

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

×

REQUEST A DEMO

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your interest

A member of the team will be in touch shortly to arrange a convenient time for your free demonstration and trial. If your enquiry is urgent, please email our Client Services team here.